Re: Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis

References

1. 1.↵
   1. Goldschmidt N,
   2. Zamir L,
   3. Poperno A,
   4. Kahan NR,
   5. Paltiel O

   . Presenting signs of multiple myeloma and the effect of diagnostic delay on the prognosis. J Am Board Fam Med 2016;29:702–9.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Bradwell A

   . Serum free light chain analysis plus Hevylite. 7th ed. Birmingham, UK: Binding Site Group Ltd; 2015.
3. 3.↵
   1. Rajkumar SV,
   2. Dimopoulos MA,
   3. Palumbo A,
   4. et al

   . International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014;15:e538–48.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Singh G

   . Serum free light chain assay and κ/λ ratio performance in patients without monoclonal gammopathies: high false-positive rate. Am J Clin Pathol 2016;146:207–14.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Kyle RA,
   2. Buadi F,
   3. Rajkumar SV

   . Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Oncology (Williston Park) 2011;25:578–86.

   OpenUrlPubMed
6. 6.↵
   1. Singh G

   . Serum free light chain assay and κ/λ ratio: performance in patients with monoclonal gammopathy-high false negative rate for κ/λ ratio. J Clin Med Res 2017;9:46–57.

   OpenUrl